Positron POSC

OTC POSC
$1.63 -0.07 (-4.12%)
At close: Oct 22, 2026 · 4:00 PM EDT

Positron (POSC) stock price is $1.63, down 4.12% on the day, as of Oct 22, 2026. It has a market cap of $53.54Mn, and is classified in the Diagnostic Equipment industry (Healthcare sector).

Key Stats
Market Cap53.54 Mn
P/E-10.92
P/S115.82
Total Debt (Qtr)2.00 Mn
Revenue Growth (1y) (Qtr)-6.91
Add ratio to table…

About

Positron Corporation is a medical technology company that co-develops, manufactures, and sells PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. The company combines proprietary PET and PET-CT systems with comprehensive clinical and technical support, flexible financing, and a focus on…

Read more ↓
Sector: Healthcare Sector rationale Positron designs, manufactures, and sells PET and PET-CT imaging systems, which are classified as medical devices. Its revenue is derived from selling these systems and providing associated clinical and technical support to hospitals and outpatient centers. Industries: Diagnostic Equipment Diagnostic Equipment Primary Positron designs, manufactures, and sells PET and PET-CT imaging systems, which are clinical diagnostic equipment used for molecular imaging in cardiology, oncology, and neurology. Revenue is generated from the sale of these systems and associated reagents/services, fitting the description of diagnostic equipment. Healthcare Services Healthcare Services Secondary The company provides clinical over-read support and billing/prior-authorization assistance to healthcare providers, which are outpatient-style healthcare services delivered to support the diagnosis and treatment of patients. Classified using BQ-MICS CIK: 0000844985

Product and Service Breakdown of Revenue (2025)

History
Peer percentiles

How Positron ranks

Ranked against the 247 companies in Medical Devices and Diagnostics58 metrics · as of Oct 23, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −10.9xMedian 29.7x 48th
  • P/FCFNegative free cash flow −12.9xMedian 24.8x 43rd
  • P/Operating cash flowNegative operating cash flow −12.9xMedian 20.2x 41st
  • P/S 116xMedian 3.03x 5th
  • P/BNegative shareholder equity −81.0xMedian 2.42x Not meaningful —
  • P/Tangible bookNegative tangible equity −81.0xMedian 3.04x Not meaningful —
  • EV/EBITDANegative EBITDA −11.6xMedian 18.0x 37th
  • EV/EBITNegative EBIT −11.5xMedian 27.0x 41st
  • EV/Revenue 119xMedian 3.09x 5th
  • EV/FCFNegative free cash flow −13.3xMedian 26.4x 37th
  • EV/Operating cash flowNegative operating cash flow −13.3xMedian 21.5x 34th
  • PEG (3Y EPS CAGR) —Median 0.97 No data —
Peer group

Peer Comparison

Companies in the Diagnostic Equipment
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 250.13 Bn35.905.4042.55 Bn
2 ABT Abbott Laboratories 180.31 Bn33.243.8732.61 Bn
3 DHR Danaher Corp /De/ 162.34 Bn40.546.4726.56 Bn
4 ISRG Intuitive Surgical Inc 158.13 Bn53.4713.66-
5 MDT Medtronic plc 122.37 Bn23.393.2628.15 Bn
6 SYK Stryker Corp 117.89 Bn31.614.5614.94 Bn
7 BSX Boston Scientific Corp 67.15 Bn18.273.2012.62 Bn
8 POSC Positron Corp 0.05 Bn-10.92115.820.00 Bn